Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. NMC.L Share Price
  4. NMC.L Share Regulatory News
  5. PDMR notification

Pin to quick picksNMC.L Regulatory News (NMC)

NMC.L Information
  • There is currently no data for NMC

PDMR notification

13 Oct 2017 09:46

RNS Number : 5506T
NMC Health Plc
13 October 2017
 

 

NMC Health plc

 

PDMR notification

 

London, 13 October 2017: NMC Health plc (LSE:NMC) ('NMC'), the leading integrated private healthcare network operator in the GCC and one of the leading global providers of fertility treatments through its European, South American and Middle Eastern subsidiaries, announces that it has received notification from Mrs Salma Hareb, an Independent Non-Executive Director of the Company, that on 12 October 2017 she purchased 6,600 ordinary shares of 10p each in the Company ("Shares") at a price of 2,970.9897p per share.

 

The Notification of Dealing Form for Mrs Hareb can be found below.

This notification is made in accordance with the Market Abuse Regulation.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Salma Ali Saif Bin Hareb

2

Reason for the notification

a)

Position/status

Independent Non-Executive Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

NMC Health plc

b)

LEI

2138008YQEVWBE1V2M52

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares

 

 

ISIN: GB00B7FC0762

b)

Nature of the transaction

Purchase of shares

 

 

c)

Price(s) and volume(s)

 Price

No. of shares

2,970.9897 pence

6,600

d)

Aggregated information

- volume

- Price

- Total

 

 

 

6,600

 

2,970.9897 pence

 

ÂŁ196,085.32

e)

Date of the transaction

12 October 2017

f)

Place of the transaction

London Stock Exchange

 

 

 

Contacts

 

 

 

Investors

 

NMC

 

Simon Watkins, Group Company Secretary

+44 (0)20 3205 7313

 

 

 

 

Media:

 

FTI Consulting, London

Brett Pollard

 +44 (0)20 3727 1000

 

FTI Consulting, Gulf

 

 

Shane Dolan

+971 (0)4 437 2100

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUOSWRBOARARA
10111213141516171819
Date   Source Headline
13th Oct 201510:23 amBUSForm 8.3 - NMC Health Plc Amendment
13th Oct 20159:39 amBUSForm 8.3 - NMC Health Plc
12th Oct 20153:21 pmBUSForm 8.3 - NMC HEALTH PLC
12th Oct 20153:10 pmRNSForm 8.3 - NMC Health Plc
12th Oct 20153:06 pmRNSForm 8.3 - NMC Health Plc
12th Oct 20153:04 pmRNSForm 8.3 - Al Noor Hospitals Group Plc
12th Oct 20152:33 pmRNSForm 8.3 - NMC HEALTH GROUP PLC
12th Oct 20151:42 pmRNSBoard Change
12th Oct 201511:35 amRNSForm 8.5 (EPT/RI)
12th Oct 201510:37 amRNSForm 8.5 (EPT/RI)-NMC Health Plc
12th Oct 20157:00 amRNSRule 2.10 Announcement
9th Oct 20153:00 pmRNSNMC Health confirms a possible offer for Al Noor
9th Oct 20152:18 pmRNSStatement re Possible Offer
28th Sep 20157:00 amRNSDirector/PDMR Shareholding
9th Sep 20151:53 pmRNSDirector/PDMR Shareholding
26th Aug 20157:00 amRNSHalf Yearly Report
25th Aug 201510:48 amRNSClosing of ProVita acquisition
24th Aug 20153:41 pmRNSNMC Opens New Super Speciality Hospital in UAE
17th Aug 20151:22 pmRNSClosing Dr Sunny Healthcare Group acquisition
10th Aug 201510:28 amRNSNotification of Half Year Results
18th Jun 20154:35 pmRNSPrice Monitoring Extension
16th Jun 20155:04 pmRNSResults of voting at Annual General Meeting
15th Jun 20157:00 amRNSAcquisition of ProVita
4th Jun 20157:05 amRNSClosing of Americare Group acquisition
4th Jun 20157:00 amRNSAppointment of J.P.Morgan Cazenove
20th May 201511:30 amRNSDirector/PDMR Shareholding
20th May 20159:00 amRNSAGM and Dividend Timetable
29th Apr 20157:00 amRNSAcquisition
7th Apr 20151:39 pmRNSNOTIFICATION IN ACCORDANCE WITH RULE 3.1.4 (1) (a)
30th Mar 20157:00 amRNSAppointment of FTI Consulting
30th Mar 20157:00 amRNSAppointment of HSBC as Joint Corporate Broker
26th Feb 20151:58 pmRNSDirector/PDMR Shareholding
26th Feb 201511:48 amRNSOptions grant award announcement
24th Feb 20157:02 amRNSAcquisition of Clinica Eugin
24th Feb 20157:00 amRNSFY 14 Results
16th Feb 20157:00 amRNSNew Financing Facility & Update to Group Strategy
30th Oct 20141:36 pmRNSNOTIFICATION MADE IN ACCORDANCE WITH RULE 3.1.4
28th Oct 20147:00 amRNSInterim Management Statement and Management Change
19th Aug 20147:00 amRNSHALF-YEARLY FINANCIAL REPORT
30th Jun 20141:00 pmRNSNOTIFICATION IN ACCORDANCE WITH RULE 3.1.4 (1)(a)
26th Jun 20144:09 pmRNSBoard Change
26th Jun 20144:07 pmRNSResults of voting at Annual General Meeting
26th Jun 201412:58 pmRNS2014 Half-Year pre-close statement
3rd Jun 20149:53 amRNSAGM and Proposed Board Changes
29th Apr 20147:00 amRNSInterim Management Statement
4th Apr 20144:12 pmRNSNOTIFICATION IN ACCORDANCE WITH RULE 3.1.4 (1) (a)
26th Mar 201410:16 amRNSBoard Change
25th Feb 20141:16 pmRNSDividend Timetable and AGM notice
25th Feb 20147:02 amRNSDirectorate Change
25th Feb 20147:00 amRNSFull Year Results ending 2013
10111213141516171819

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
BXP
Beximco Pharma
LSE
0.00%
ADN
ADN.L
LSE
0.00%
BAB
Babcock
LSE
-1.61%
SNR
Senior
LSE
0.00%
RDSA
RDSA.L
LSE
0.00%
Trending
GST
GSTechnologies
LSE
4.04%
GGP
Greatland Resources
LSE
-0.61%
PREM
Premier African Minerals
LSE
-2.78%
LLOY
Lloyds
LSE
0.40%
80M
80 Mile
LSE
-4.65%